CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 22, 2006--POZEN Inc.
(NASDAQ: POZN), announced today that it will release fourth quarter
and year end results on March 1, 2006, before the market opens. It was
previously scheduled for March 2, 2006.
The announcement will be followed by a live webcast at 11:00 a.m.
Eastern Time of a discussion by POZEN management of the earnings and
business results. The webcast can be accessed on POZEN's website at
www.pozen.com and will be archived and available for replay. The
fourth quarter/year end earnings release can be accessed in the News
section of POZEN's website.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of acute and chronic
pain, migraine, and other pain-related conditions. POZEN has a
development and commercialization alliance with GlaxoSmithKline. The
company's common stock is traded on The Nasdaq Stock Market under the
symbol "POZN". For detailed company information, including copies of
this and other press releases, see POZEN's website: www.pozen.com.
Bill Hodges, 919-913-1030
Chief Financial Officer
Fran Barsky, 919-913-1044
Director, Investor Relations